emraclidine
M4 positive allosteric modulator Ph. II for schizophrenia discovery not disclosed Lancet, December 17, 2022 Cerevel Therapeutics, Cambridge, MA
Molecules of the Month - December 2022
5 minute read
Jan. 28, 2023
Emraclidine: A Pioneering M4 Positive Allosteric Modulator